GlassScriptPhysician profile
Charlene Sauer
NPI 1174829840
$707.28
in general payments reported to CMS, 2019-2025
12 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $247 · 2023: $111 · 2024: $75.74 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $253.70 | 2021-2025 | Ozempic, Rybelsus |
| Insulet Corporation | $78.26 | 2023-2025 | Omnipod, Omnipod |
| Abbvie INC. | $78.18 | 2021-2023 | |
| Abbott Laboratories | $63.53 | 2022-2024 | Freestyle Libre 3 |
| Amgen INC. | $49.49 | 2025 | Krystexxa |
| Pfizer INC. | $47.99 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $32.33 | 2022 | |
| Astellas Pharma US INC | $27.15 | 2023 | Veozah |
| Smith+Nephew, INC. | $24.92 | 2021 | |
| Dexcom, INC. | $19.46 | 2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $17.57 | 2021 | |
| Exact Sciences Corporation | $14.70 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlene Sauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.